A detailed history of Cora Capital Advisors LLC transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Cora Capital Advisors LLC holds 47,235 shares of IDNA stock, worth $1.17 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
47,235
Previous 47,415 0.38%
Holding current value
$1.17 Million
Previous $1.1 Billion 6.06%
% of portfolio
0.57%
Previous 0.56%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$22.86 - $25.49 $4,114 - $4,588
-180 Reduced 0.38%
47,235 $1.16 Billion
Q2 2024

Aug 02, 2024

BUY
$21.71 - $24.69 $65,021 - $73,946
2,995 Added 6.74%
47,415 $1.1 Billion
Q1 2024

Apr 18, 2024

BUY
$22.28 - $25.2 $64,589 - $73,054
2,899 Added 6.98%
44,420 $1.07 Billion
Q4 2023

Feb 05, 2024

BUY
$17.37 - $23.3 $82,125 - $110,162
4,728 Added 12.85%
41,521 $955 Million
Q3 2023

Oct 10, 2023

BUY
$20.35 - $24.44 $84,594 - $101,597
4,157 Added 12.74%
36,793 $749 Million
Q2 2023

Jul 18, 2023

BUY
$23.05 - $25.1 $375,761 - $409,180
16,302 Added 99.8%
32,636 $762 Million
Q1 2023

May 04, 2023

BUY
$22.48 - $27.9 $367,188 - $455,718
16,334 New
16,334 $380 Million

Others Institutions Holding IDNA

About ISHARES TR GENOMICS IMMUNOLOGY


  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track Cora Capital Advisors LLC Portfolio

Follow Cora Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cora Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cora Capital Advisors LLC with notifications on news.